Â鶹´«Ã½¸ßÇå

The Caris Precision Oncology Alliance™ (POA) unites over 95 premier cancer centers and academic institutions, including more than 45 NCI-designated comprehensive cancer centers, to advance precision medicine. By integrating molecular testing into cancer care, contributing longitudinal data, and conducting collaborative research, the alliance drives innovation in clinical-genomic solutions. Explore how the POA fosters groundbreaking studies and publications that shape the future of oncology on the Caris AI page.

Flatiron is a cutting-edge technology platform that transforms electronic health records (EHRs) from cancer care providers across the U.S. into robust, real-world datasets. By offering de-identified, longitudinal data on over 3.5 million patients, Flatiron empowers researchers to explore key aspects of the cancer patient journey, including demographics, treatments, and outcomes. CU Cancer Center investigators can leverage these curated datasets, including clinico-genomic cohorts, through a proposal-based process via Flatiron Explore. Learn more about Flatiron.

The Oncology Research Information Exchange Network (ORIEN) unites North America’s leading cancer centers to accelerate discovery through collaboration and shared data. Supported by M2Gen, ORIEN leverages the Total Cancer Care® protocol, enabling partners to access a vast repository of clinically annotated cancer tissue and data from over 240,000 patients. This innovative approach empowers researchers to track molecular, clinical, and epidemiological data throughout a patient’s lifetime, driving advancements in targeted treatments. Learn more about ORIEN.